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To determine the modes of three disulfide linkages in the heat-stable enterotoxin (STh) produced by a human 
strain of enterotoxigenic Es herichia coli, we synthesized STh(6-18), which consists f 13 amino acid residues 
and has the same intramolecular disulfide linkages a native STh [(1985) FEBS Lett. 181, 138-142], by step- 
wise and selective formation of disulfide bonds using different types of removable protecting groups for the 
Cys residues. Synthesis of the peptide with different modes of disulfide bond formation provided three pep- 
tides consistent with standard STh(6-18) in their physicochemical and biological properties, thereby indicat- 
ing that the disulfide bonds in STh(6-18) are 
I 1 
Cys-Cys-Glu-Leu-Cys-Cys-Asn-Pro-Ala-Cys-Thr-Gly-Cys. 
" I " I 
Thermal stability; Enterotoxin; Disulfide bond; (E. coil) 
1. INTRODUCTION 
Enterotoxigenic Escherichia coli elaborates two 
kinds of heat-stable nterotoxins (STI and STII), 
which are responsible for acute diarrhea in 
children in developing countries in the tropics and 
in domestic animals [1]. STI acts on ST-sensitive 
cells to stimulate guanylate cyclase and to raise the 
level of cyclic GMP in the cells [2-5], but the mode 
of biological action of STII is unknown [6]. STIs 
have been purified from the culture supernatant of
human, bovine and porcine strains of enterotox- 
igenic E. coli and their primary structures with 18 
or 19 amino acid residues have been determined 
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[7-9], as shown in fig. 1. We named the STIs from 
human and porcine strains of E. coli STh and STp, 
respectively. The full enterotoxigenic activity of 
STI has been found to be expressed by a segment 
with 13 amino acid residues, which includes 6 half- 
cystines [10]. Recently, STI-like enterotoxins from 
Yersinia enterocolitica [11,12], Vibrio cholerae 
non-01 [13], and V. mimicus (unpublished) have 
been isolated and sequenced (fig.l). These 
enterotoxins have common regions with 13 amino 
acid residues including 6 Cys residues, which are 
located in the same relative positions and linked in- 
tramolecularly by three disulfide bonds. The 
enterotoxins of Y. enterocolitica nd V. cholerae 
non-01 have similar biological and physicochemi- 
cal properties to those f  STI of E. coil, suggesting 
that these enterotoxins have the same disulfide 
bonds and therefore similar tertiary structures. 
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Fig.1. Amino acid sequences of heat-stable enterotoxins produced by enteric bacteria: a, see [7]; b, see [8,9]; c, see 
I1 l, 12]; d, see [13]; e, unpublished. The single letter notations used are cited from [14]. 
Detailed information on the conformation of STI 
is necessary for defining the reactive site(s) on STI 
for expression of the toxicity of STI, an anti-STI 
antibody recognition site(s), and the mechanism of 
the biological system involving STI. On the basis 
of the chemical syntheses of STI analogues with 13 
amino acid residues and various kinds of disulfide 
bonds and their physicochemical nd biological 
properties, in this paper we propose the mode of 
disulfide bond formation in STI. 
2. MATERIALS AND METHODS 
2.1. Materials and apparatus 
All chemicals and solvents were reagent grade 
unless otherwise described. CH3CN was distilled 
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Fig.2. Scheme for synthesis of a shorter analogue, STh(6-18), of a heat-stable enterotoxin (ST,) of E. coli by stepwise 
formation of disulfide bonds. 
166 
Volume 215, number 1 FEBS LETTERS May 1987 
from phosphorus pentoxide before use for HPLC. 
The HPLC apparatus consisted of a Hitachi 655 li- 
quid chromatograph equipped with a multiwave 
ultraviolet monitor, type 655M (Tokyo, Japan). A 
reversed-phase r sin (YMC-ODS, S-5) was pur- 
chased from Yamamura Chemical Laboratories 
(Kyoto, Japan) and packed into a column (4.6 × 
250 mm) in our laboratory. 
2.2. Syntheses of peptides 
Peptide synthesis was performed manually by 
the solid-phase method [15]. The following pro- 
tecting groups for functional groups were used, t- 
butyloxycarbonyl for-amino groups; 4-methylben- 
zyl (MBzl) or acetamidomethyl (Acm) for thiol 
groups of cysteine residues; and benzyl for the - 
carboxyl of glutamic acid and the hydroxyl group 
of threonine. The protected peptide resin (70 mg) 
containing -0.01 mmol peptide was treated with 
anisole in anhydrous liquid hydrogen fluoride 
(HF) [16] at 0°C for 60 min for cleavage of the 
peptidyl resin linkage and removal of all the pro- 
tecting groups except Acm groups at given Cys 
residues. The HF was removed on evaporation i
vacuo, and the resulting peptide was extracted into 
10% aqueous formic acid (3 ml), washed three 
times with hexane, and air-oxidized in dilute solu- 
tion (200 ml) at pH 8.0, until no free thiol group 
was detectable. The solution was lyophilized and 
the residual material was purified by HPLC, as 
described below. The purified peptide with Acre 
groups at given Cys residues was dissolved at 5 × 
10-4M in MeOH-H20 (v/v, 4: 1), dropped into 
the same volume of MeOH-1 M HCI (v/v, 4: 1) 
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Fig.3. Sets of peptides synthesized by the procedure described in fig.2. Thin lines indicate disulfide bonds formed first, 
and thick lines those formed finally. Numbers denote positions of Cy residues linked selectively by a disulfide bond. 
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containing 12 (40 equivalents of the sample pep- 
tide), and stood for 15 min at room temperature 
[17]. The reaction was stopped by adding L- 
ascorbic acid and the reaction product was directly 
purified by HPLC.  
2.3. Purification of synthetic peptides 
The air-oxidized or I2-oxidized peptide was 
purified by HPLC on a reversed-phase column. 
The peptide was eluted with a linear gradient of 
10-40°70 CH3CN in 0.05070 trifluoroacetic acid or 
0.01 M ammonium acetate (pH 5.7) with increase 
of CH3CN concentration of 0.5070/min or l%/min  
at a flow rate of 1 ml/min. Fractions of eluate 
were monitored for absorbance at 220 nm. 
2.4. Analysis of purified peptides 
The amino acid compositions and molecular 
masses of purified peptides were examined by 
amino acid analysis and fast atom bombardment 
mass spectrometry, respectively, as described [12]. 
2.5. Biological assay 
Toxic activity was assayed in suckling mice of 
2 -4  days old as described [18]. 
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3. RESULTS AND DISCUSSION 
Reduction of the disulfide bonds in STI results 
in loss of its toxic activity, indicating that the ter- 
tiary structure formed by the disulfide bonds is 
necessary for expression of this toxicity. We 
previously found that the sequences of both STh 
and ST o consisting of 13 amino acids and including 
6 half-cystine residues have the same toxic ac- 
tivities as native toxins [10]. These findings sug- 
gested that the structural information for the 
biological properties of STI is involved in the 
segments formed from these 13 amino acid 
residues. 
Two general procedures for determination of 
disulfide bridges in peptides and proteins (partial 
acid or enzymatic hydrolysis of peptides and pro- 
teins and selective reduction and alkylation of 
disulfide bonds in peptides and proteins) were ap- 
plied for determination of the disulfide bonds of 
STh, but without success. Therefore, in this work, 
we adopted a stepwise synthetic procedure to form 
disulfide bonds using selectively removable pro- 
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Fig.4. Reversed-phase HPLC of (A) a deprotected and 
air-oxidized solution of peptides with two disulfide 
bonds at position 7, 10, 15, and 18; (B) a deprotected 
and air-oxidized solution of peptides with two disulfide 
bonds at positions 6, 10, 11, and 18; (C) a deprotected 
and air-oxidized solution of peptides with two disulfide 
bonds at positions 6, 7, 11, and 15; (D) a deprotected 
and air-oxidized solution of peptides with a disulfide 
bond at positions 7 and 15; (E) an I2-oxidized solution 
of peak 1 in A; (F) an I2-oxidized solution of peak 5 in 
B; (G) an I2-oxidized solution of peak 6 in C; (H) an 
I2-oxidized solution of peak 7 in D. 
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Table 1 
Amino acid compositions a, mass values and toxic activities of synthetic STh(6-18) b 
Peak 8 Peak 9 Peak 10 Peak 11 Peak 12 Peak 13 Theoretical 
value 
Asp 1.00 1.03 1.03 1.00 1.00 1.11 1 
Thr 1.01 0.99 1.01 1.03 1.02 1.03 1 
Giu 1.03 1.02 1.05 1.02 1.02 1.06 1 
Gly 0.96 0.99 1.04 1.00 1.05 1.05 1 
Ala 1 1 1 1 1 1 1 
Cys 4.74 4.39 5.37 5.13 4.96 5.26 6 
Leu 1.11 0.97 1.00 1.10 1.02 1.04 1 
Pro 0.98 1.09 1.01 0.98 0.92 0.96 1 
[M+H] ÷ 1313.1 1313.2 1313.2 1313.3 1313.2 1313.1 1313.4 
MED c 9 0.7 12 10 0.9 0.3 0.6 a 
a Values are those in acid hydrolysates (110°C, 24 h) of synthetic peptides and are 
shown as mol/mol of Ala 
b Peak 8, 9, etc. correspond to those in fig.4 
c MED, minimum effective dose 
a This value is cited from [10] 
tecting groups at Cys residues, as shown in fig.2, 
and selectively synthesized peptides with nine sets 
of disulfide bonds: that is, between 6 and 10, 6 and 
11, 6 and 15, 6 and 18, 7 and 10, 7 and 15, 7 and 
18, 10 and 15, and 10 and 18, as shown in fig.3. Of 
the peptides with ese sets of disulfide bonds, the 
three in which two disulfide bonds were first 
formed between four Cys residues except Cys-6 
and Cys-11 or Cys-10 and Cys-18 and the remain- 
ing one disulfide bond then between Cys-6 and 
Cys-11 or Cys-10 and Cys-18, respectively, or one 
disulfide bond was first formed between Cys-7 and 
Cys-15 and the remaining two disulfide bonds then 
between the remaining four Cys residues, were 
identical on HPLC with standard STh(6-18), as 
shown in fig.4. Other peptides did not have the 
same retention time as standard STh(6-18) on 
HPLC.  
The amino acid compositions and mass values of 
the peptides obtained were identical with the 
theoretical values for STh(6--18) within the limits 
of experimental error, as summarized in table 1. 
Moreover, the toxicities, that is the minimum ef- 
fective doses, of these peptides were 0.3-1.0 ng, 
which were almost the same as that (0.6 ng) of 
standard STh(6--18) [10]. These activities were 
cB, 
Chemical shifts 
Fig.5. 500 MHz 1H-NMR spectra in a mixture of 
CD3CN and DMSO-d6 (v/v, 15:85). (A) A peptide 
linked between Cys-6 and Cys-ll as a third disulfide 
bond and (B) standard STh(6-18). 
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I I 
Cys-Cys-G] u-Leu-Cys-Cys-Asn-Pro-A] a-Cys-Thr-Gly-Cys 
l ' l "  l 
Fig.6. Mode of three disulfide linkages of ST~(6-18). 
neutralized by anti-native STh polyclonal an- 
tibodies. Furthermore, the 1H-NMR spectra of 
these peptides were identical with that of standard 
STh(6-18), as shown in fig.5. 
Thus, we conclude that the disulfide linkages in 
STh(6-18) are formed between Cys-6 and Cys-11, 
Cys-7 and Cys-15, and Cys-10 and Cys-18, as 
shown in fig.6. We recently found that STp(5-17), 
which has Ala in place of Thr in STn(6-18), has the 
same disulfide bonds as STh(6--18) (not shown). 
This indicates that E. coli-STh and STp have the 
same disulfide bonds as those shown in fig.6. 
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